基于贝叶斯网络的皮肤状细胞癌的治疗决策模型
Eenas Ghura1, Jan Gaebel2, Thomas Neumuth2
1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, 04103 Leipzig, Germany.
Cancers
|February 27, 2026
概括
贝叶斯网络有助于选择高级皮肤状细胞癌 (cSCC) 的治疗方法. 这种人工智能工具在指导皮肤癌患者的临床决策方面实现了95.5%的准确性.
科学领域:
- 在瘤学瘤学.
- 人工智能在医学中的应用
- 临床决策支持系统 临床决策支持系统
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种常见的非黑色素瘤皮肤癌,通常通过手术治疗.
- 系统疗法,包括像Cemiplimab这样的免疫检查点抑制剂,对于高级或不可操作的cSCC至关重要.
- 塞米普利马布为高级cSCC患者提供了新的治疗途径,这些患者不适合常规疗法.
研究的目的:
- 开发利用贝叶斯网络 (BNs) 的临床决策支持工具,以进行最佳的cSCC治疗选择.
- 将包括临床,组织学和遗传因素在内的各种患者数据纳入决策模型.
- 在复杂的治疗规划中解决缺失或不确定数据的挑战.
主要方法:
- 在cSCC中开发贝叶斯网络 (BN) 模型,用于治疗策略建议.
- 包括患者特异性数据:瘤类型,阶段和PD-L1表达.
- 以后验证使用66名cSCC或基底细胞癌 (BCC) 患者的数据.
主要成果:
- 该BN模型在治疗建议中显示出95.5%的高整体准确性.
- 与多学科瘤董事会决策相比,模型的表现具有统计学意义 (p < 0.001).
- 该工具有效地管理了治疗计划的复杂患者数据.
结论:
- 贝叶斯网络 (BNs) 是在瘤学中建模复杂的临床决策过程的有效工具.
- 开发的BN工具在提高cSCC患者的治疗选择方面显示出希望.
- 这种方法通过整合全面的患者数据来支持个性化医疗.
关键词:
贝叶斯网络是一个贝叶斯网络.这是一种PD-1抑制剂.人工智能的人工智能是人工智能.cSCCCC 的意思是什么?临床决策支持系统 (CDSS)皮肤状细胞癌瘤免疫检查点抑制剂 免疫检查点抑制剂免疫疗法 免疫疗法分子瘤板是一个分子瘤板.变化的景观.更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
789
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
15.5K
相关概念视频
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
